FOSL2 and neoplasm: By binding to JUN (also JUNB or JUND) or FOS, FOS (also FOSB, FRA1 or FRA2) forms a well-known heterodimeric or homodimeric transcription factor AP-1 which could be oncogenic or tumor-suppressive depending on the cell type (5, 6).